ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial

<p>Abstract</p> <p>Background</p> <p>A recently published systematic review indicated superiority of duodenum-preserving techniques when compared with pancreatoduodenectomy, for the treatment of patients with chronic pancreatitis in the head of the gland. A multicentre...

Full description

Bibliographic Details
Main Authors: Schlitt Hans, Glanemann Matthias, Halloran Christopher, Contin Pietro, Bruckner Thomas, Diener Markus K, Mössner Joachim, Kieser Meinhard, Werner Jens, Büchler Markus W, Seiler Christoph M
Format: Article
Language:English
Published: BMC 2010-04-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/11/1/47
id doaj-53b12c65aa5f4b6bbb23a43c5c2d4352
record_format Article
spelling doaj-53b12c65aa5f4b6bbb23a43c5c2d43522020-11-25T01:03:00ZengBMCTrials1745-62152010-04-011114710.1186/1745-6215-11-47ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trialSchlitt HansGlanemann MatthiasHalloran ChristopherContin PietroBruckner ThomasDiener Markus KMössner JoachimKieser MeinhardWerner JensBüchler Markus WSeiler Christoph M<p>Abstract</p> <p>Background</p> <p>A recently published systematic review indicated superiority of duodenum-preserving techniques when compared with pancreatoduodenectomy, for the treatment of patients with chronic pancreatitis in the head of the gland. A multicentre randomised trial to confirm these results is needed.</p> <p>Methods/Design</p> <p>ChroPac aims to investigate differences in quality of life, mortality and morbidity during 24 months after surgery (duodenum-preserving pancreatic head resection versus pancreatoduodenectomy) in patients with chronic pancreatitis of the pancreatic head.</p> <p>ChroPac is a randomised, controlled, observer and patient blinded multicentre surgical trial with two parallel comparison groups. The primary outcome measure will be the average quality of life during 24 months after surgery. Statistical analysis is based on the intention-to-treat population. Analysis of covariance will be applied for the intervention group comparison adjusting for age, centre and quality of life before surgery. Level of significance is set at 5% (two-sided) and sample size (n = 100 per group) is determined to assure a power of 90%.</p> <p>Discussion</p> <p>The ChroPac trial will explore important outcomes from different perspectives (e.g. surgeon, patient, health care system). Its pragmatic approach promises high external validity allowing a comprehensive evaluation of the surgical strategy for treatment of patients with chronic pancreatitis.</p> <p>Trial registration</p> <p>Controlled-trials.com ISRCTN38973832</p> http://www.trialsjournal.com/content/11/1/47
collection DOAJ
language English
format Article
sources DOAJ
author Schlitt Hans
Glanemann Matthias
Halloran Christopher
Contin Pietro
Bruckner Thomas
Diener Markus K
Mössner Joachim
Kieser Meinhard
Werner Jens
Büchler Markus W
Seiler Christoph M
spellingShingle Schlitt Hans
Glanemann Matthias
Halloran Christopher
Contin Pietro
Bruckner Thomas
Diener Markus K
Mössner Joachim
Kieser Meinhard
Werner Jens
Büchler Markus W
Seiler Christoph M
ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
Trials
author_facet Schlitt Hans
Glanemann Matthias
Halloran Christopher
Contin Pietro
Bruckner Thomas
Diener Markus K
Mössner Joachim
Kieser Meinhard
Werner Jens
Büchler Markus W
Seiler Christoph M
author_sort Schlitt Hans
title ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
title_short ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
title_full ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
title_fullStr ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
title_full_unstemmed ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial
title_sort chropac-trial: duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. trial protocol of a randomised controlled multicentre trial
publisher BMC
series Trials
issn 1745-6215
publishDate 2010-04-01
description <p>Abstract</p> <p>Background</p> <p>A recently published systematic review indicated superiority of duodenum-preserving techniques when compared with pancreatoduodenectomy, for the treatment of patients with chronic pancreatitis in the head of the gland. A multicentre randomised trial to confirm these results is needed.</p> <p>Methods/Design</p> <p>ChroPac aims to investigate differences in quality of life, mortality and morbidity during 24 months after surgery (duodenum-preserving pancreatic head resection versus pancreatoduodenectomy) in patients with chronic pancreatitis of the pancreatic head.</p> <p>ChroPac is a randomised, controlled, observer and patient blinded multicentre surgical trial with two parallel comparison groups. The primary outcome measure will be the average quality of life during 24 months after surgery. Statistical analysis is based on the intention-to-treat population. Analysis of covariance will be applied for the intervention group comparison adjusting for age, centre and quality of life before surgery. Level of significance is set at 5% (two-sided) and sample size (n = 100 per group) is determined to assure a power of 90%.</p> <p>Discussion</p> <p>The ChroPac trial will explore important outcomes from different perspectives (e.g. surgeon, patient, health care system). Its pragmatic approach promises high external validity allowing a comprehensive evaluation of the surgical strategy for treatment of patients with chronic pancreatitis.</p> <p>Trial registration</p> <p>Controlled-trials.com ISRCTN38973832</p>
url http://www.trialsjournal.com/content/11/1/47
work_keys_str_mv AT schlitthans chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT glanemannmatthias chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT halloranchristopher chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT continpietro chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT brucknerthomas chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT dienermarkusk chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT mossnerjoachim chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT kiesermeinhard chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT wernerjens chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT buchlermarkusw chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
AT seilerchristophm chropactrialduodenumpreservingpancreaticheadresectionversuspancreatoduodenectomyforchronicpancreatitistrialprotocolofarandomisedcontrolledmulticentretrial
_version_ 1725202778242940928